Department of Core Antisense Research, Ionis Pharmaceuticals, Inc., 2855 Gazelle Court, Carlsbad, CA, 92010, USA.
Adv Exp Med Biol. 2017;983:129-146. doi: 10.1007/978-981-10-4310-9_9.
A number of diseases are caused by low levels of key proteins; therefore, increasing the amount of specific proteins in human bodies is of therapeutic interest. Protein expression is downregulated by some structural or sequence elements present in the 5' UTR of mRNAs, such as upstream open reading frames (uORF). Translation initiation from uORF(s) reduces translation from the downstream primary ORF encoding the main protein product in the same mRNA, leading to a less efficient protein expression. Therefore, it is possible to use antisense oligonucleotides (ASOs) to specifically inhibit translation of the uORF by base-pairing with the uAUG region of the mRNA, redirecting translation machinery to initiate from the primary AUG site. Here we review the recent findings that translation of specific mRNAs can be enhanced using ASOs targeting uORF regions. Appropriately designed and optimized ASOs are highly specific, and they act in a sequence- and position-dependent manner, with very minor off-target effects. Protein levels can be increased using this approach in different types of human and mouse cells, and, importantly, also in mice. Since uORFs are present in around half of human mRNAs, the uORF-targeting ASOs may thus have valuable potential as research tools and as therapeutics to increase the levels of proteins for a variety of genes.
一些疾病是由关键蛋白质水平低引起的;因此,增加人体中特定蛋白质的数量具有治疗意义。mRNA 5'UTR 中存在的一些结构或序列元件,如上游开放阅读框(uORF),下调蛋白质表达。从 uORF 起始翻译会减少同一 mRNA 中编码主要蛋白质产物的下游主 ORF 的翻译,从而导致蛋白质表达效率降低。因此,可以使用反义寡核苷酸(ASO)通过与 mRNA 的 uAUG 区域碱基配对来特异性抑制 uORF 的翻译,从而将翻译机制重新定向到主 AUG 位点起始。在这里,我们回顾了最近的发现,即使用针对 uORF 区域的 ASO 可以增强特定 mRNA 的翻译。经过适当设计和优化的 ASO 具有高度特异性,并且以序列和位置依赖性方式发挥作用,几乎没有脱靶效应。使用这种方法可以在不同类型的人和小鼠细胞中增加蛋白质水平,重要的是,在小鼠中也可以增加蛋白质水平。由于 uORF 存在于大约一半的人类 mRNA 中,因此 uORF 靶向 ASO 可能具有作为研究工具和治疗剂的有价值的潜力,以增加各种基因的蛋白质水平。